Journals / Türk Oftalmoloji Dergisi / 2011 / Cilt: 41 - Sayı: 3

Retınopathy of Prematurıty Rısk Factors, Prognosıs and Treatment

Prematüre Retinopatisinde Klinik Seyir, Tedavinin Değerlendirilmesi ve ilişkili Risk Faktörlerinin Belirlenmesi

Pages
128–132
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Effective screening, follow-up and appropriate treatment are important for prevention of permanent damage and unfavorable outcome in ROP. (Turk J Ophthalmol 2011; 41: 128-32)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the prevalence, related risk factors, treatment and follow-up results in cases of retinopathy of prematurity (ROP).
📊
Key Findings & Data:Material and Method: Medical records of 405 premature infants who attended our clinic between August 1999 and September 2004 were retrospectively screened.
💡
Conclusion & Impact:Effective screening, follow-up and appropriate treatment are important for prevention of permanent damage and unfavorable outcome in ROP. (Turk J Ophthalmol 2011; 41: 128-32)
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the prevalence, related risk factors, treatment and follow-up results in cases of retinopathy of prematurity (ROP). Material and Method: Medical records of 405 premature infants who attended our clinic between August 1999 and September 2004 were retrospectively screened. Among these patients, 379 infants were followed up in our neonatology unit and 26 were referred to us from other clinics. Indirect diode laser photocoagulation and/or cryotherapy were performed when prethreshold or threshold ROP was detected. Surgery was performed in stage IV-V ROP. Results: ROP was detected in 88 out of 405 infants (21.72%). At the first examination, stage I ROP was detected in 18 eyes (10.4%), stage II - in 67 eyes (38.72%), stage III - in 82 eyes (47.39%), and stage IV-V – in 6 eyes (3.46%). Indirect diode laser photocoagulation was applied to 34 eyes with stage II and in 47 eyes with stage III ROP. Ten eyes with threshold ROP and 4 eyes which progressed to threshold ROP were treated with cryotherapy. Scleral buckling was performed in 3 eyes that progressed to stage IV ROP. At the first examination, 2 eyes with stage IV-V ROP were treated with pars plana vitrectomy (PPV). Discussion: In our series, the most important risk factors for development and progression of ROP were found to be low birth weight, low gestational age, mechanical ventilation and multiple pregnancy. Effective screening, follow-up and appropriate treatment are important for prevention of permanent damage and unfavorable outcome in ROP. (Turk J Ophthalmol 2011; 41: 128-32)

Özet

Amaç: Prematüre bebeklerde prematüre retinopatisi (ROP) sıklığını, ilişkili risk faktörlerini, tedavi ve izlem sonuçlarını değerlendirmek. Gereç ve Yöntem: Ağustos 1999-Eylül 2004 tarihleri aras›nda kliniğimizde izlenen 405 prematüre bebeğin kayıtları retrospektif olarak taranmıştır. Bu hastaların 379’u hastanemiz yenidoğan bakım ünitesinde izlenmiş, 26’s› dış merkezlerden gönderilmiştir. Eşik veya eşikaltı evreye ulaşan bebeklere diod laser fotokoagülasyon ve/veya kriyoterapi, evre IVV’e cerrahi tedavi uygulanmıştır. Sonuçlar: Takip edilen 405 bebeğin 88’inde (%21,72) prematüre retinopatisi saptanmıştır. ‹lk muayenede retinopati 18 gözde evre I (%10,4), 67 gözde evre II (%38,72), 82 gözde evre III (%47,39), 6 gözde evre IV-V (%3,46) düzeyinde bulunmuştur. Evre II’de 34 göze, evre III’te 47 göze indirekt diod laser, eşik hastalık saptanan 10 göze ve eşik hastalığa ilerleme gözlenen 4 göze kriyoterapi, evre IV’e ilerleyen 3 göze skleral çökertme, ilk muayenede evre IV-V tespit edilen 2 göze Pars Plana Vitrektomi (PPV) uygulanmıştır. Tartışma: Serimizde düşük doğum ağırlığı, düşük gestasyon yaşı›, mekanik ventilatör tedavisi ve çoğul gebeligin prematüre retinopatisi gelişiminde etkili risk faktörleri olduğu saptanmıştır. Etkin tarama, düzenli izlem ve uygun tedavi prematüre retinopatisinde kalıcı hasarların önlenmesinde gereklidir. (Turk J Ophthalmol 2011; 41: 128-32).

🔖

Cite This Article

KADAYIFCILAR, S., KOCABEYOĞLU, S., ELDEM, B. (2022). Retınopathy of Prematurıty Rısk Factors, Prognosıs and Treatment. Türk Oftalmoloji Dergisi, Cilt: 41 - Sayı: 3, 128–132. https://ajindex.com/articles/638370

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistant vascular sheath behind each crystalline lens. Am J Ophthalmol. 1942;25:203-4. Committee for the classification of retinopathy of prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;106:471-9. Patz A. An international classification of retinopathy of prematurity. II. The classification of retinal detachment. Arch Ophthalmol. 1987;105:906-12.
  2. Ng YK, Fielder AR, Shaw DE, Levere MI. Epidemiology of retinopathy of prematurity. Lancet. 1988;2:1235-8.
  3. Kinsey VE, Jacobus JT, Hemphill F. Retrolental fibroplasias: cooperative study of Retrolental fibroplasia and the use of oxygen. Arch Ophthalmol. 1956;56:481-547.
  4. Mahashwari R, Kumar H, Paul VK, Singh M, Deorari AK, Tiwari HK. ‹ncidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. National Med J India. 1996;9:211-4.
  5. Charan R, Dogram R, Gupta A, Nonarang A. The incidence retinopathy of prematurity in a neonatal care unit. Indian J Ophthalmol. 1995;43:123-6. Cryotherapy for retinopathy of prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity; preliminary results. Arch Ophthalmol. 1988;106:471-9.
  6. Gupta VP, Dalival U, Sharma R, Gupta P, Rohatgi J. Retinopathy of prematurity, risk facctors.Indian J Pediatr. 2004;71:887-92.
  7. Gezer A, Sezen F, fierifo¤lu I, Karaçorlu M. Management of reti nopathy of prematurity with cryotherapy. Eur J Ophthalmol. 1999;9:49-52.
  8. Altunbafl HH, K›r N, Oval› T, Da¤o¤lu T. Prematüre retinopatisi:klinik seyir ve risk faktörleri. Turk J Ophthalmol 2002;32:286-90.
  9. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Philips CL, Schaffer DB, Tung B. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-40.
  10. Bozkurt N, Anveriazer M, Ö¤üt MS, Kazoko¤lu H, Bavbek T, Özek E. Prematüre retinopatisi, risk faktörleri ve takip sonuçları. Turk J Ophthalmol. 1999;29:149-56.
  11. Conrath JG, Hadjadj EJ, Forzano O, et al. Screening for retinopathy of prematurity:results of a retrospective 3 year study of 502 infants. J Pediatr Ophthalmol Strabismus. 2004;41:31-4.
  12. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye (Lond). 1992;6:233-42.
  13. Kinsey VE, Arnold HJ, Kalina RE, et al. PaO2 levels and retrolental fibroplasia; a report of the cooperative study. Pediatrics. 1977;60:655-68.
  14. Clark C, Gibbs JA, Maniello R, Outerbridge EW, Aranda JV.